Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease
about
Animal models of GM2 gangliosidosis: utility and limitationsTherapeutic response in feline sandhoff disease despite immunity to intracranial gene therapy.A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS Gene therapy in Canavan mice.Influence of a ketogenic diet, fish-oil, and calorie restriction on plasma metabolites and lipids in C57BL/6J mice.Multi-system disorders of glycosphingolipid and ganglioside metabolismBis(monoacylglycero)phosphate: a secondary storage lipid in the gangliosidoses.Clinical utility of neuronal cells directly converted from fibroblasts of patients for neuropsychiatric disorders: studies of lysosomal storage diseases and channelopathyAAV-mediated gene delivery in a feline model of Sandhoff disease corrects lysosomal storage in the central nervous system.Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis modelReversibility of neuropathology in Tay-Sachs-related diseases.Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation.Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease.Adeno-associated virus-mediated expression of β-hexosaminidase prevents neuronal loss in the Sandhoff mouse brain.Cerebral organoids derived from Sandhoff disease induced pluripotent stem cells exhibit impaired neurodifferentiation.Ethylenedioxy-PIP2 oxalate reduces ganglioside storage in juvenile Sandhoff disease mice.Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson's Disease.
P2860
Q26738663-1206775D-E930-4E7D-931A-30866FB32682Q30541192-A00E8218-4F92-4FD6-8B91-69B855B18776Q30559496-A3E6ED77-450B-4E9F-A512-CE1432DBF64AQ33718016-9003E78B-F547-42E0-8522-8154C63C1D62Q33902037-5AC75BEB-8AA4-4057-9E6E-07F215879AA0Q35536363-9BDFFEA9-56C5-4B69-84F3-76F7E7498388Q35597578-A1E7D663-D860-4231-8839-E56186E33848Q36482816-F04F3115-12BF-4138-9D97-D0DBF72D200EQ36867296-F860FBA2-6B8A-4C4F-A4FA-754C775849B4Q37463989-78DF0AA5-0E6A-4902-8CBA-26E06CD9C32CQ37622642-1DE8069F-7847-4B6C-8C85-F201FAFB0892Q42177668-4AE7EBB1-D8C4-4637-9DAB-DEE5405ECE0EQ45364010-82A2FCFA-B295-46EB-82A4-6A1ED2AF4350Q47846451-C888F14C-CDD8-437D-A5D7-3479B260053EQ48159574-DD1E877D-4304-4E11-96B1-4DCAB0E581C4Q55412876-B6CCED40-6CF1-4F03-BDC6-002883CCA937
P2860
Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease
@ast
Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease
@en
type
label
Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease
@ast
Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease
@en
prefLabel
Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease
@ast
Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease
@en
P2093
P2860
P1433
P1476
Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease
@en
P2093
Douglas R Martin
Nancy R Cox
Rena C Baek
P2860
P2888
P304
P356
10.1007/S11745-008-3268-0
P577
2008-11-26T00:00:00Z